APR-246 Enhances the Anticancer Effect of Doxorubicin Against p53-Mutant AsPC-1 Pancreatic Cancer Cells. Baghdad Sci.J 2024, 21 (8), 2551. https://doi.org/10.21123/bsj.2024.10135.